Evolent Health layoffs, on the record
Every job cut, severance charge and restructuring Evolent Health reported in its annual reports, 2023 to 2025, quoted from the filings. Headcount went from approximately 4,700 to approximately 4,200.
Headcount, as reported
| Annual report | Employees | As of |
|---|---|---|
| 10-K for 2023 | approximately 4,700 | December 31, 2023 |
| 10-K for 2024 | approximately 4,500 | December 31, 2024 |
| 10-K for 2025 | approximately 4,200 | February 16, 2026 |
Job cuts, severance and restructuring
Our summaryImplemented the 2023 Repositioning Plan, a set of initiatives with organizational changes that resulted in severance, terminated benefits and related costs to streamline operations.
Word for word“During the second quarter of 2023, the Company implemented a broad set of repositioning initiatives designed to further align the Company's assets and talent towards the value-based specialty care opportunity, with the intent of streamlining its operations and supporting the goal of realizing long-term sustainable earnings growth (the "2023 Repositioning Plan')."” 10-K for 2023
Our summaryReported total repositioning plan costs for 2023, including severance, dedicated employee costs, professional services and office space consolidation.
Word for word“The repositioning program is anticipated to be substantially complete by the first half of 2024.” 10-K for 2023
Our summaryRecorded severance costs within selling, general and administrative expenses for 2023.
Word for word“The increase was primarily driven by the NIA transition services administration fee of $30.0 million, higher personnel fees due to increased headcount from the acquisition of NIA and expected benefit accruals to employees of $22.7 million, higher stock compensation of $9.2 million due to the achievement and change in projected achievement of certain performance measurements, 54 higher bad debt expense of $2.3 million due to collection timing from our customers, technology services due to higher headcount of $3.9 million, $1.5 million of severance costs and acquisition costs of $15.1 million.” 10-K for 2023
Our summaryRecorded severance payments to former employees within cost of revenue for 2023.
Word for word“Cost of revenue also included $91.0 million of higher personnel costs due to increased headcount from our acquisitions, employee benefit, bonus accruals for employees and severance payments to former employees and $58.3 million of surgical management costs at IPG.” 10-K for 2023
Our summaryRecorded severance costs within cost of revenue for 2022, prior-year comparison.
Word for word“The increase included approximately $253.8 million from higher claims cost from acquisitions and transition from ASO to risk based contracts for certain customers, $33.6 million of higher personnel costs due to increased headcount, employee benefits and bonus accruals for employees, $22.1 million in higher professional fees primarily due to costs incurred for contracts that went live during the year and third-party service fees for existing customers, $40.9 million of surgical management costs at IPG and $12.3 million of severance costs.” 10-K for 2023
Our summaryThe company implemented a 2023 Repositioning Plan of organizational changes that resulted in severance and termination benefits, aimed at streamlining operations.
Word for word“During the second quarter of 2023, the Company implemented a broad set of repositioning initiatives designed to further align the Company's assets and talent towards the value-based specialty care opportunity, with the intent of streamlining its operations and supporting the goal of realizing long-term sustainable earnings growth (the "2023 Repositioning Plan").” 10-K for 2024
Our summaryThe 2023 Repositioning Plan was completed.
Word for word“The 2023 Repositioning Plan was completed during the second quarter of 2024.” 10-K for 2024
Our summaryThe company paid severance and related payments in operating cash flows and reported severance in its cash flow discussion.
Word for word“Cash flows provided by operating activities of $18.8 million for the year ended December 31, 2024 were affected by increases in accounts receivable of $32.1 million from timing of our partner and vendor payments including higher cash receipts from certain performance-based customers, offset by a reduction reserve for claims and performance-based arrangements of $85.3 million due to the timing of claims payments and a reduction in accrued compensation and benefits of $22.7 million due to the timing of 2023 bonus payments, severance of $2.9 million and payments for office lease consolidation and termination of $8.4 million.” 10-K for 2024
Our summarySelling, general and administrative expenses rose in 2025 partly because of higher severance costs.
Word for word“The increase was primarily driven by higher personnel costs of $24.4 million including increased severance of $7.3 million, higher professional fees of $6.7 million driven by transaction costs, higher technology costs including cloud services of $5.8 million, a $2.1 million increase in bad debt expense versus the prior period reflecting a return to normal collections timing and higher stock compensation expense due to the achievement and change in projected achievement of certain performance measurements of $1.3 million, offset by lower lease expense of $4.2 million due to the termination of certain real estate leases.” 10-K for 2025
| Fiscal year ended | Severance costs | Restructuring charges |
|---|---|---|
| 2016-12-31 | $0 | — |
| 2017-12-31 | $0 | — |
| 2018-12-31 | $2.2 million | $0 |
| 2019-12-31 | $17.4 million | $0 |
| 2020-12-31 | $9 million | $1.3 million |
| 2021-12-31 | $198,000 | $7.3 million |
| 2022-12-31 | $13.3 million | $0 |
Evolent Health has filed no restructuring notice (Form 8-K, Item 2.05) since 2016. Companies file one only for a cut they judge material, so many announced layoffs never appear as one. This page shows what the company reported to the SEC, not news reports or state layoff notices.
Read from Evolent Health’s annual reports (10-K for 2025, 10-K for 2024, 10-K for 2023) and the financial data it files with the SEC, as of 2026-02-25. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.